The Global Oligonucleotide Pool Market is expected to reach $2.32 billion by 2022. The report providing a detail analysis of the Oligonucleotide pool industry structure along with forecast for the next 6 years related to various segments and sub-segments of the market.

Pune, India -- (SBWire) -- 05/25/2018 --Global Oligonucleotide Pool Market has Been Segmented on the basis of types which comprises of DNA pool, RNA pool. On the basis of application the market is segmented into research, diagnostics & therapeutics, and others. Furthermore on the bases of end users the market is segmented into commercial research, pure academic research and others.

Key Findings

The oligonucleotide pool global market and is expected to reach $2.32 billion by 2022.

DNA pool holds the largest share of 66.9% of the market.

Globally, Asia-Pacific the fastest growing region and expected to grow at the CAGR of 9.2% during the forecast period.

Top Oligonucleotide Pool Market Players Business Overview:

Agilent Technologies, Creative Biogene, CustomArray, Inc, Integrated DNA Technologies, Inc., MYcroarray, Sigma Aldrich, TriLink BioTechnologies, and Twist Bioscience.

Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/2556 .

Oligonucleotide Pool Market Scenario:

It has been noted that global oligonucleotide pool market is growing at moderate pace and is expected to grow at the CAGR of 8.5%. Oligonucleotide pool market is driven by three major factors such as huge investments from big pharmaceutical companies in oligonucleotide therapeutics for drug development, CMO's involvement in manufacturing therapeutic oligonucleotides and wide application areas offered by the oligonucleotides.

There is only small number of approved oligonucleotide drugs available in the market. Currently there are only three drugs available in the U.S. Very few of the oligonucleotide drug sponsors have their own in-house cGMP manufacturing facilities. On the other hand, more than half of the oligonucleotides in the clinical development stage are manufactured by the contract manufacturing organizations (CMO). As more number of oligonucleotides are on the verge of regulatory approval, the demand for such oligonucleotides will increase in the market. The increased demand is likely to force the CMO's to increase their capacity and improve efficiency in manufacturing the oligonucleotides. CMO's are adopting different strategies to increase the manufacturing capacity. For example, in 2014, German CMO BioSpring added a midscale synthesizer to increase the capacity. Nitto Denko Avecia, the leading CMO has implemented the use of thin film evaporation in order to concentrate product solutions prior to lyophilisation which results in larger final batches of custom oligos. The increasing involvement of the CMOs in order to cater to the demand of oligonucleotides is likely to boost the growth of the oligonucleotide pool market.

 Oligonucleotide Pool Market Regional Analysis:

As per Market Research Future analysis, the global oligonucleotide pool market has grown tremendously in Asia-Pacific. Geographically, North America holds the largest share of more than 42.2% of oligonucleotide pool market and is expected to be the leading market during 2016-2022. The major factor that influences the growth of the North American oligonucleotide pool market is the existence of large number of small scale and big scale manufacturers of oligonucleotide pool and service providers in the region.

After North America region, Europe market is the second largest market in the global oligonucleotide pool market. Increasing investment by organizations in the field of genomics serves as a significant driver for this region. Whereas Asia Pacific region is expected to be the fastest growing market due to increasing R&D funding by the developing countries like China and India for the development of oligonucleotide products.

Major TOC For Oligonucleotide Pool Market Research Report- Global Forecast To 2022:

1  REPORT PROLOGUE

2  MARKET INTRODUCTION

2.1 Definition

2.2 Scope Of Study

2.3 Research Objective

2.4 Assumptions & Limitations

2.4.1 Assumptions

2.4.2 Limitations

2.5 Market Structure

3  RESEARCH METHODOLOGY

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

4   MARKET DYNAMICS

4.1 Introduction

4.2 Drivers

4.2.1 Big Pharmaceutical Companies Investing In Oligonucleotide Therapeutics For Drug Development

4.2.2 Increased Involvement Of CMOs In Manufacturing Therapeutic Oligonucleotides.

4.2.3 Wide Application Areas Offered By The Oligonucleotides

4.3 Restraints

4.3.1 Complexity In The Manufacturing Technique And Inaccuracy Of Oligonucleotides.

4.4 Opportunities

Ask Question to Experts @ https://www.marketresearchfuture.com/enquiry/2556 .

TOC Continued….!

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.